Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème
0.2.1 - ci-build France flag

Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème - Local Development build (v0.2.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Définition des phase de l'essai utilisés dans la base de données ECLAIRE - JSON Representation

Draft as of 2024-01-08

Raw json | Download


{
  "resourceType" : "CodeSystem",
  "id" : "eclaire-study-phase-source-code-system",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">jarde-early<a name=\"eclaire-study-phase-source-code-system-jarde-early\"> </a></td><td>Jardé phase précoce</td></tr><tr><td style=\"white-space:nowrap\">phase-I-first-admin<a name=\"eclaire-study-phase-source-code-system-phase-I-first-admin\"> </a></td><td>Human Pharmacology (Phase I) - First administration to humans</td></tr><tr><td style=\"white-space:nowrap\">phase-I-bioequivalence<a name=\"eclaire-study-phase-source-code-system-phase-I-bioequivalence\"> </a></td><td>Human Pharmacology (Phase I) - Bioequivalence Study</td></tr><tr><td style=\"white-space:nowrap\">phase-I-other<a name=\"eclaire-study-phase-source-code-system-phase-I-other\"> </a></td><td>Human Pharmacology (Phase I) -  Other</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-first-admin<a name=\"eclaire-study-phase-source-code-system-phase-I-II-first-admin\"> </a></td><td>Phase I and Phase II (Integrated) - First administration to humans</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-first-bioequivalence<a name=\"eclaire-study-phase-source-code-system-phase-I-II-first-bioequivalence\"> </a></td><td>Phase I and Phase II (Integrated) - Bioequivalence Study</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-other<a name=\"eclaire-study-phase-source-code-system-phase-I-II-other\"> </a></td><td>Phase I and Phase II (Integrated) - Other</td></tr><tr><td style=\"white-space:nowrap\">phase-II<a name=\"eclaire-study-phase-source-code-system-phase-II\"> </a></td><td>Therapeutic exploratory (Phase II)</td></tr><tr><td style=\"white-space:nowrap\">phase-II-III<a name=\"eclaire-study-phase-source-code-system-phase-II-III\"> </a></td><td>Phase II and Phase III (Integrated)</td></tr><tr><td style=\"white-space:nowrap\">phase-III<a name=\"eclaire-study-phase-source-code-system-phase-III\"> </a></td><td>Therapeutic confirmatory  (Phase III)</td></tr><tr><td style=\"white-space:nowrap\">phase-IV<a name=\"eclaire-study-phase-source-code-system-phase-IV\"> </a></td><td>Therapeutic use (Phase IV)</td></tr><tr><td style=\"white-space:nowrap\">phase-III-IV<a name=\"eclaire-study-phase-source-code-system-phase-III-IV\"> </a></td><td>Phase III and phase IV (Integrated)</td></tr></table></div>"
  },
  "url" : "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system",
  "version" : "0.2.1",
  "name" : "EclaireStudyPhaseSourceCS",
  "title" : "Définition des phase de l'essai utilisés dans la base de données ECLAIRE",
  "status" : "draft",
  "date" : "2024-01-08T08:40:48+00:00",
  "publisher" : "ANS",
  "contact" : [
    {
      "name" : "ANS",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://esante.gouv.fr"
        }
      ]
    }
  ],
  "description" : "Définition des phases de l'essai utilisées dans la base de données ECLAIRE",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "FR",
          "display" : "FRANCE"
        }
      ]
    }
  ],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 12,
  "concept" : [
    {
      "code" : "jarde-early",
      "display" : "Jardé phase précoce"
    },
    {
      "code" : "phase-I-first-admin",
      "display" : "Human Pharmacology (Phase I) - First administration to humans"
    },
    {
      "code" : "phase-I-bioequivalence",
      "display" : "Human Pharmacology (Phase I) - Bioequivalence Study"
    },
    {
      "code" : "phase-I-other",
      "display" : "Human Pharmacology (Phase I) -  Other"
    },
    {
      "code" : "phase-I-II-first-admin",
      "display" : "Phase I and Phase II (Integrated) - First administration to humans"
    },
    {
      "code" : "phase-I-II-first-bioequivalence",
      "display" : "Phase I and Phase II (Integrated) - Bioequivalence Study"
    },
    {
      "code" : "phase-I-II-other",
      "display" : "Phase I and Phase II (Integrated) - Other"
    },
    {
      "code" : "phase-II",
      "display" : "Therapeutic exploratory (Phase II)"
    },
    {
      "code" : "phase-II-III",
      "display" : "Phase II and Phase III (Integrated)"
    },
    {
      "code" : "phase-III",
      "display" : "Therapeutic confirmatory  (Phase III)"
    },
    {
      "code" : "phase-IV",
      "display" : "Therapeutic use (Phase IV)"
    },
    {
      "code" : "phase-III-IV",
      "display" : "Phase III and phase IV (Integrated)"
    }
  ]
}